IPO
-
-
-
-
-
-
-
Humacyte Announces Publication of In Vivo Data on Biovascular Pancreas Transplantation for the Treatment of Type 1 Diabetes
-
-
-
-
-
-
-
UPDATE -- Humacyte Expands Strategic Global Partnership with Fresenius Medical Care
-
-
-
-
-
-
-
Humacyte to Provide Investor Update on June 7
-
-
-
-
-
-
-
Humacyte Leadership and Investigators to Present at Five Scientific Events in May
-
-
-
-
-
-
-
Humacyte to Present Long-Term Follow-Up Data from Phase 2 Vascular Access Trial at Charing Cross (CX) International Symposium 2021
-
-
-
-
-
-
118,853 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

